Previous 10 | Next 10 |
ViewRay (NASDAQ: VRAY ) announces that Stanford, CA-based Stanford Health Care will acquire a MRIidian radiotherapy device, apparently under a collaboration agreement, although it does provide the details of said agreement. More news on: ViewRay, Inc., Healthcare stocks news, Read mo...
CLEVELAND , Sept. 12, 2019 /PRNewswire/ -- ViewRay, Inc. (NASDAQ: VRAY) announced today that Stanford Health Care in Stanford, California , will acquire a MRIdian, the world's leading MR-guided radiation therapy system. MRIdian integrates MRI technology, radiation delivery, and...
CLEVELAND , Sept. 10, 2019 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) announced today that the company's MRIdian® and MRIdian Linac MRI-guided radiation therapy systems will be featured at the 2019 Annual Meeting of the American Society for Radiation Oncology (ASTRO), being he...
Shares of medical-device maker ViewRay (NASDAQ: VRAY) tumbled 56% in August, according to data provided by S&P Global Market Intelligence . That more than erased the gains the stock had seen during the first half of the year, as shares dropped to their lowest point since ...
CLEVELAND , Aug. 27, 2019 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) today announced that the Company will host a physician-led informational discussion for investors and analysts during the 2019 American Society of Radiation Oncology (ASTRO) Annual Meeting in Chicago . ...
This Weekly Short Newsletter is normally exclusive to PRO+ Subscribers. We're making this one available to all readers. SA PRO+ is our institutional-grade subscription offering targeted to buysiders and serious investors. If you enjoyed this report, and would like to subscribe or learn more ...
CLEVELAND , Aug. 19, 2019 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) announced today the acceptance of publication by the International Journal of Radiation Oncology, Biology and Physics of the first prospective clinical trial of MR-guided radiation therapy (MRgRT) in patients with...
CLEVELAND , Aug. 15, 2019 /PRNewswire/ -- ViewRay, Inc. (NASDAQ: VRAY) today announced that the Company will participate in two upcoming investor conferences in New York, NY . An audio webcast of the Company's presentations will be available on the events and webinars section of...
Thesis Correct, Shorts Win I initially wrote up VRAY as a short in July of 2017 ( here ). The short thesis has played out exactly as expected with the only surprise coming from how long it took for the short to work. VRAY bulls certainly put up a good fight over the last two years but it...
Gainers : Arcadia Biosciences (NASDAQ: RKDA ) +49% . Soliton (NASDAQ: SOLY ) +24% . GTT Communications (NYSE: GTT ) +17% . Everspin Technologies (NASDAQ: MRAM ) +16% . AMAG Pharmaceuticals (NASDAQ: AMAG ) +15% . China SXT Pharmaceuticals (NASDAQ: SXTC ) +15% . TrueCar (NASDAQ: T...
News, Short Squeeze, Breakout and More Instantly...
ViewRay® Announces Commencement of Nasdaq Delisting Proceedings: Common Stock Expected to Begin Trading on the OTC Markets PR Newswire DENVER , July 21, 2023 /PRNewswire/ -- ViewRay, Inc. (the "Company") (Nasdaq: VRAY) announced today that on July 17 , i...